600976
vs
S
Shanghai Composite
600976
Over the past 12 months, Jianmin Pharmaceutical Group Co Ltd has underperformed Shanghai Composite, delivering a return of -18% compared to the Shanghai Composite's +25% growth.
Stocks Performance
600976 vs Shanghai Composite
Performance Gap
600976 vs Shanghai Composite
Performance By Year
600976 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Jianmin Pharmaceutical Group Co Ltd
Glance View
Jianmin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacturing, wholesale and retail of pharmaceutical products. The company is headquartered in Wuhan, Hubei and currently employs 2,004 full-time employees. The company went IPO on 2004-04-19. The firm operates its businesses through two segments, including Pharmaceutical Industry and Pharmaceutical Business. The Pharmaceutical Industry segment is engaged in the research and development and manufacture of pharmaceuticals. Its products are mainly applied in children, women and the elderly, among others. The Pharmaceutical Business segment is engaged in the wholesale and retailing of pharmaceuticals. Its products include traditional Chinese medicine, Western medicine, health products, medical equipment and chemical agents. The company distributes its products mainly in domestic market.
